Wednesday, September 28th
5 p.m., EM029, Center for Molecular Medicine Conference Room
Charles Drinnan, Ph.D.
Treatment and Modelling of Neonatal Lung Diseases Using Patient-Specific Stem Cells
COVID-19: Vaccine Program | Testing | Visitor Guidelines | Information for Employees
Notice of a Data Incident
Wednesday, September 28th
5 p.m., EM029, Center for Molecular Medicine Conference Room
Charles Drinnan, Ph.D.
Treatment and Modelling of Neonatal Lung Diseases Using Patient-Specific Stem Cells